Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Carcinoma, Non-Small-Cell Lung 21Ovarian Neoplasms 18Lung Neoplasms 14Breast Neoplasms 13Endometrial Neoplasms 12Fallopian Tube Neoplasms 11Parkinson Disease 4, Autosomal Dominant Lewy Body 10Neoplasm Metastasis 10Squamous Cell Carcinoma of Head and Neck 7Triple Negative Breast Neoplasms 5Neoplasms 4Esophageal Squamous Cell Carcinoma 4Esophageal Neoplasms 4Carcinoma 4Adenocarcinoma Of Esophagus 4Stomach Neoplasms 3Melanoma 3Colorectal Neoplasms 3Adenocarcinoma 3Uterine Neoplasms 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Small Cell Lung Carcinoma 2Peritoneal Neoplasms 2HER2-positive Breast Cancer 2Cholangiocarcinoma 2Carcinoma, Transitional Cell 2Brenner Tumor 2Advanced Solid Tumour 2Adenocarcinoma, Bronchiolo-Alveolar 2

Interventions

Paclitaxel 2Carboplatin 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1sapanisertib 1relatlimab 1pertuzumab 1pembrolizumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1erdafitinib 1defactinib 1dabrafenib 1copanlisib 1capivasertib 1binimetinib 1adavosertib 1X-Rays 1Trastuzumab 1Sutures 1Sunitinib 1Specimen Handling 1Radionuclide Imaging 1PF-05280014 1Ontruzant 1Ogivri 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Uterine Neoplasms × Paclitaxel × 30 days × Clear all
NCT06107868 2026-06-10

GyneRep

University Health Network, Toronto

Phase 1 Active not recruiting
6 enrolled
Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms, Uterine Neoplasms

NCT07044336 2026-06-10

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

AstraZeneca

Phase 3 Recruiting
800 enrolled
Gynecologic

Neoplasm Metastasis, Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡